Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor Among Patients With Cystic Fibrosis and Advanced Lung Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease
Chest 2024 Mar 21;[EPub Ahead of Print], A Gramegna, G Alicandro, C Premuda, F Lucca, L Pinali, M Retucci, V Vespro, MC Andrisani, G Carraffiello, F Amati, S Volpi, S Aliberti, M Cipolli, F BlasiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.